In patients who do require chronic treatment, the smallest dose and the shortest duration of treatment producing a satisfactory clinical response should be sought.
Compliance an Issue
This site was written for US residents. Serum prolactin levels increased in a dose-dependent manner up to 6- and 1. Oral supplementation should be continued for 3 weeks after the first injection until the main release of risperidone from the injection site has begun. Get patient coverage information, and depending on your area, receive help with injection administration and inpatient to outpatient transition.
Adverse reactions that were associated with discontinuation from the double-blind, placebo-controlled periods of the bipolar disorder trials were hyperglycemia one patient in the monotherapy trial and hypokinesia and tardive dyskinesia one patient each in the adjunctive treatment trial.
Rarely, males may have a painful or prolonged erection lasting 4 or more hours.
Neither the renal or adrenal tumors, nor osteodystrophy, were seen in studies of orally administered risperidone. A head-to-head comparison of risperidone and haloperidol found 1-year relapse rates were Respiratory, thoracic and mediastinal disorders: Cardiovascular monitoring should commence immediately and should include continuous electrocardiographic monitoring to detect possible arrhythmias. A must-read every morning. In some cases, this condition may be permanent.
Dosages above 50 mg have not been studied in this population.
Patients with clinically significant neutropenia should be carefully monitored for fever or other symptoms or signs of infection and treated promptly if such symptoms or signs occur.
A long-acting form of the second-generation antipsychotic drug risperidone is now broadly available for the treatment of schizophrenia and closely related psychiatric conditions.
These effects were all noted at the one dose of risperidone tested, i. This, in turn, may inhibit reproductive function by impairing gonadal steroidogenesis in both female and male patients.
We want to guide you to programs that may help. The smaller numbers of patients in the current study may explain the differences in significance in PANSS total scores at endpoint.
Ear and Labyrinth Disorders: